Cite

MLA Citation

    Marcus Vetter et al.. “SAKK 21/12: a phase II trial of transdermal CR1447 in breast cancer patients.” Endocrine oncology, vol. 2, no. 1, 2022, pp. 9–18. http://access.bl.uk/ark:/81055/vdc_100167957088.0x000001
  
Back to record